Provence Angels and Grand Delta Angels joined Kinathera’s historical investors to finance in vivo proof of concept of Kinathera’s first in class inhibitor BT8401
Provence Angels and Grand Delta Angels joined Kinathera’s historical investors to finance in vivo proof of concept of Kinathera’s first in class inhibitor BT8401